AZN vs NRXS · P/E 28, $288.38B cap vs rev $3.6M
AstraZeneca PLC (AZN) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
AZN does not have a complete income-statement cache yet.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the AZN and NRXS stock pages for the full models.
Not investment advice.